116 related articles for article (PubMed ID: 16741180)
1. Reduction of tissue plasminogen activator-induced matrix metalloproteinase-9 by simvastatin in astrocytes.
Wang S; Lee SR; Guo SZ; Kim WJ; Montaner J; Wang X; Lo EH
Stroke; 2006 Jul; 37(7):1910-2. PubMed ID: 16741180
[TBL] [Abstract][Full Text] [Related]
2. Simvastatin inhibits MMP-9 secretion from human saphenous vein smooth muscle cells by inhibiting the RhoA/ROCK pathway and reducing MMP-9 mRNA levels.
Turner NA; O'Regan DJ; Ball SG; Porter KE
FASEB J; 2005 May; 19(7):804-6. PubMed ID: 15728660
[TBL] [Abstract][Full Text] [Related]
3. Statins Suppress TGF-β2-Mediated MMP-2 and MMP-9 Expression and Activation Through RhoA/ROCK Inhibition in Astrocytes of the Human Optic Nerve Head.
Kim ML; Sung KR; Kwon J; Shin JA
Invest Ophthalmol Vis Sci; 2020 May; 61(5):29. PubMed ID: 32421147
[TBL] [Abstract][Full Text] [Related]
4. Simvastatin inhibits TNFalpha-induced invasion of human cardiac myofibroblasts via both MMP-9-dependent and -independent mechanisms.
Turner NA; Aley PK; Hall KT; Warburton P; Galloway S; Midgley L; O'Regan DJ; Wood IC; Ball SG; Porter KE
J Mol Cell Cardiol; 2007 Aug; 43(2):168-76. PubMed ID: 17560598
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of RhoA/Rho-kinase pathway suppresses the expression of type I collagen induced by TGF-beta2 in human retinal pigment epithelial cells.
Itoh Y; Kimoto K; Imaizumi M; Nakatsuka K
Exp Eye Res; 2007 Mar; 84(3):464-72. PubMed ID: 17217948
[TBL] [Abstract][Full Text] [Related]
6. Statins inhibit secretion of metalloproteinases-1, -2, -3, and -9 from vascular smooth muscle cells and macrophages.
Luan Z; Chase AJ; Newby AC
Arterioscler Thromb Vasc Biol; 2003 May; 23(5):769-75. PubMed ID: 12663370
[TBL] [Abstract][Full Text] [Related]
7. Statins suppress MMP2 secretion via inactivation of RhoA/ROCK pathway in pulmonary vascular smooth muscles cells.
Li M; Li Z; Sun X
Eur J Pharmacol; 2008 Sep; 591(1-3):219-23. PubMed ID: 18619957
[TBL] [Abstract][Full Text] [Related]
8. Tissue plasminogen activator promotes matrix metalloproteinase-9 upregulation after focal cerebral ischemia.
Tsuji K; Aoki T; Tejima E; Arai K; Lee SR; Atochin DN; Huang PL; Wang X; Montaner J; Lo EH
Stroke; 2005 Sep; 36(9):1954-9. PubMed ID: 16051896
[TBL] [Abstract][Full Text] [Related]
9. Statin prevents tissue factor expression in human endothelial cells: role of Rho/Rho-kinase and Akt pathways.
Eto M; Kozai T; Cosentino F; Joch H; Lüscher TF
Circulation; 2002 Apr; 105(15):1756-9. PubMed ID: 11956113
[TBL] [Abstract][Full Text] [Related]
10. Lipoprotein receptor-mediated induction of matrix metalloproteinase by tissue plasminogen activator.
Wang X; Lee SR; Arai K; Lee SR; Tsuji K; Rebeck GW; Lo EH
Nat Med; 2003 Oct; 9(10):1313-7. PubMed ID: 12960961
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of Rho/Rho-kinase signaling downregulates plasminogen activator inhibitor-1 synthesis in cultured human monocytes.
Ishibashi T; Nagata K; Ohkawara H; Sakamoto T; Yokoyama K; Shindo J; Sugimoto K; Sakurada S; Takuwa Y; Teramoto T; Maruyama Y
Biochim Biophys Acta; 2002 Jun; 1590(1-3):123-30. PubMed ID: 12063175
[TBL] [Abstract][Full Text] [Related]
12. 3-Hydroxy-3-methylglutaryl CoA reductase inhibitors prevent high glucose-induced proliferation of mesangial cells via modulation of Rho GTPase/ p21 signaling pathway: Implications for diabetic nephropathy.
Danesh FR; Sadeghi MM; Amro N; Philips C; Zeng L; Lin S; Sahai A; Kanwar YS
Proc Natl Acad Sci U S A; 2002 Jun; 99(12):8301-5. PubMed ID: 12048257
[TBL] [Abstract][Full Text] [Related]
13. Simvastatin elicits dilation of isolated porcine retinal arterioles: role of nitric oxide and mevalonate-rho kinase pathways.
Nagaoka T; Hein TW; Yoshida A; Kuo L
Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):825-32. PubMed ID: 17251484
[TBL] [Abstract][Full Text] [Related]
14. Statins inhibit cyclooxygenase-2 and matrix metalloproteinase-9 in human endothelial cells: anti-angiogenic actions possibly contributing to plaque stability.
Massaro M; Zampolli A; Scoditti E; Carluccio MA; Storelli C; Distante A; De Caterina R
Cardiovasc Res; 2010 May; 86(2):311-20. PubMed ID: 19946014
[TBL] [Abstract][Full Text] [Related]
15. Simvastatin suppresses the progression of experimentally induced cerebral aneurysms in rats.
Aoki T; Kataoka H; Ishibashi R; Nozaki K; Hashimoto N
Stroke; 2008 Apr; 39(4):1276-85. PubMed ID: 18309148
[TBL] [Abstract][Full Text] [Related]
16. HMG-CoA reductase inhibitor fluvastatin prevents angiotensin II-induced cardiac hypertrophy via Rho kinase and inhibition of cyclin D1.
Morikawa-Futamatsu K; Adachi S; Maejima Y; Tamamori-Adachi M; Suzuki J; Kitajima S; Ito H; Isobe M
Life Sci; 2006 Aug; 79(14):1380-90. PubMed ID: 16712874
[TBL] [Abstract][Full Text] [Related]
17. Statins prevent pulsatile stretch-induced proliferation of human saphenous vein smooth muscle cells via inhibition of Rho/Rho-kinase pathway.
Kozai T; Eto M; Yang Z; Shimokawa H; Lüscher TF
Cardiovasc Res; 2005 Dec; 68(3):475-82. PubMed ID: 16098957
[TBL] [Abstract][Full Text] [Related]
18. Protective effects of statins involving both eNOS and tPA in focal cerebral ischemia.
Asahi M; Huang Z; Thomas S; Yoshimura S; Sumii T; Mori T; Qiu J; Amin-Hanjani S; Huang PL; Liao JK; Lo EH; Moskowitz MA
J Cereb Blood Flow Metab; 2005 Jun; 25(6):722-9. PubMed ID: 15716855
[TBL] [Abstract][Full Text] [Related]
19. Induction of matrix metalloproteinase, cytokines and chemokines in rat cortical astrocytes exposed to plasminogen activators.
Lee SR; Guo SZ; Scannevin RH; Magliaro BC; Rhodes KJ; Wang X; Lo EH
Neurosci Lett; 2007 Apr; 417(1):1-5. PubMed ID: 17386975
[TBL] [Abstract][Full Text] [Related]
20. The 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor simvastatin reduces thrombolytic-induced intracerebral hemorrhage in embolized rabbits.
Lapchak PA; Han MK
Brain Res; 2009 Dec; 1303():144-50. PubMed ID: 19781532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]